Illinois GLP-1 coverage
Nearly every document in this tier is written by a pharmacy program. Illinois's is written by a legislature. The statute creates a coverage duty for the state employees' program, names prediabetes and obesity among the qualifying diagnoses, covers on-label and off-label prescribing alike, and makes continued coverage conditional on participating in a lifestyle management plan. In the same period the state's attorney general was warning residents about who else is selling these drugs.
What changed, and what the document says
A statute section with its own name
CoveredThe heading is the finding: Illinois legislated a coverage category for this class of drug instead of leaving it to a formulary.
“Sec. 6.11C. Coverage for injectable medicines to improve glucose or weight loss.”
Illinois General Assembly — LRB103 30390 HLH 56820 b; source note: (Source: P.A. 103-8, eff. 1-1-24.)
What it requires, in full
CoveredThree qualifying diagnoses, on-label or off-label prescribing, and a physician's determination of medical necessity.
“the State Employees Group Insurance Program shall provide coverage for all types of medically necessary, as determined by a physician licensed to practice medicine in all its branches, injectable medicines prescribed on-label or off-label to improve glucose or weight loss for use by adults diagnosed or previously diagnosed with prediabetes, gestational diabetes, or obesity.”
Illinois General Assembly — LRB103 30390 HLH 56820 b; source note: (Source: P.A. 103-8, eff. 1-1-24.)
Staying covered means joining a program
Conditions applyThe condition is written into the statute rather than added by the plan, and it is triggered by written notice.
“covered members must, if given advance, written notice, participate in a lifestyle management plan administered by their health plan.”
Illinois General Assembly — LRB103 30390 HLH 56820 b; source note: (Source: P.A. 103-8, eff. 1-1-24.)
Retirees on a Medicare drug plan are outside it
Conditions applyThe carve-out is explicit, which matters because it excludes a large part of the covered population.
“This Section does not apply to individuals covered by a Medicare Advantage Prescription Drug Plan.”
Illinois General Assembly — LRB103 30390 HLH 56820 b; source note: (Source: P.A. 103-8, eff. 1-1-24.)
The legislature flagged its own start date
ContextThe section carries a caveat about a delayed effective date, printed by the legislature. We do not state a start date from this document, because the operative clause is amendatory text whose struck-through portion no extractor can resolve.
“(This Section may contain text from a Public Act with a delayed effective date)”
Illinois General Assembly — LRB103 30390 HLH 56820 b; source note: (Source: P.A. 103-8, eff. 1-1-24.)
The attorney general on who else is selling
Not coveredAn enforcement action rather than a coverage rule, and the most useful Illinois document for anyone buying these drugs online.
“Recently, my office issued cease and desist letters calling on five med spas to stop using language that misleads consumers about the products they are purchasing.”
Office of the Illinois Attorney General Kwame Raoul — January 03, 2025
Named formulations to avoid
Not coveredThe alert is specific about what is being sold: forms of these drugs that have never been tested in people.
“such as drops, skin patches and nasal sprays”
Office of the Illinois Attorney General Kwame Raoul — January 03, 2025
Which of these companies serve Illinois?
Of the 242 companies we grade, 25 publish a list of the states they are licensed in. We checked 214 more and found no such list on any page we read; 3 we have not checked either way.
18 of those lists name Illinois: Gala Health, Care Bare Rx, Vita Bella, TelePeptide, Levity, Wisp, WePeptideRx, Ways2Well, TeleClinic, Tyde Wellness, Willow, VevaRx, Trimi, Enhance MD, HumeCare+, Rx.com, Mojoon and Peak Wellness. That is a licensure claim each company makes about itself, not something we checked with a state board.
A published list is a starting point, not a guarantee. If availability decides your choice, ask before you pay and get the answer in writing.
Sources
Each document below was fetched and read on the date shown beside it, which is the date printed on the document — not always the date in its web address. All of them were read in September 2026, the same session as the rest of this page.
- HB3641 Enrolled — AN ACT concerning State government (5 ILCS 375/6.11C) — Illinois General Assembly. Drafting stamp and the section's own source note. ⛔ The operative start date is struck through in the amendatory text and is NOT reproduced anywhere on this page: LRB103 30390 HLH 56820 b; source note: (Source: P.A. 103-8, eff. 1-1-24.).
- Updated Consumer Alert: Attorney General Raoul Reminds Illinois Residents to Be Vigilant When Seeking GLP-1 Drugs for Weight Loss — Office of the Illinois Attorney General Kwame Raoul. Publication date printed on the release. Its own title says "Updated" — an earlier version exists and was not located: January 03, 2025.
Nothing on this page is medical advice, and nobody here is a clinician. Coverage rules change; check the linked document before you rely on it.
If you're paying cash instead
None of the above changes what a telehealth seller charges you. 2 of these 3 bill a fee every month on top of the medication, so the figure is the two added together. The other 1 says in the cell what we could capture and what we could not. Every number was read on the seller's own page; the adding up is ours.
Ro, LifeMD and Hims pay us nothing — none of the 3 below does. The buttons run through our own redirect so we can count the click, and counting is all they do.
| Grade | Provider | What a month actually costs | The one thing that matters here | Go to the provider |
|---|---|---|---|---|
| BMinor gap | Ro | $349a month, medication onlybrand semaglutideMedication only. We captured no separate monthly charge on the pages we read, which is what we found rather than proof that nothing else is billed.Advertised at $199The lowest of the 2 medication prices we captured here | Brand-name semaglutide at $349 and tirzepatide at $449, dispensed as the manufacturer's product, which is what the attorney general's alert is steering people toward. | See its prices at Ro (opens in a new tab)Pays us nothing |
| CCaveat | LifeMD | $298a month, everything billed monthly$149 brand semaglutide + $149 a month for membershipMandatory clinician & program fee, billed separately from the medication prices above — LifeMD does not publish a combined total.LifeMD's oral Wegovy tablet, medication only — same separate $149/mo program fee applies (first month $39).The lowest of the 3 medication prices we captured here | Advertises $199 for a Wegovy pen and bills a separate $149 monthly program fee its own FAQ calls mandatory — the kind of two-part price a statute-mandated benefit does not have. | See its prices at LifeMD (opens in a new tab)Pays us nothing |
| CCaveat | Hims | $298a month, everything billed monthly$149 brand semaglutide + $149 a month for membershipThe Weight Loss Membership itself. It runs $39 the first month and renews at $149 a month, is billed separately from the medication, and Hims says medication is not available without it.This is the medication price for the Wegovy oral pill. Hims states on the same page that the figure covers medication only and that an active Weight Loss Membership, billed separately, is required.The lowest of the 4 medication prices we captured here | Brand semaglutide at $149 and $199 and tirzepatide at $299, all manufacturer product — useful in a state whose attorney general is warning about unapproved versions. | See its prices at Hims (opens in a new tab)Pays us nothing |
Our grading method and how we verify a price explain what those letters mean and where these figures came from.